ETAM INJ
ETAMSYLATE 250MG/2ML INJ (AMPS)
What it does
Etamsylate is a medication used to help control bleeding.
Commonly used for: heavy menstrual bleeding (menorrhagia), bleeding after surgery, bleeding due to injury
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:23:24 · updated 2026-08-03 02:09:44
About etamsylate
Etamsylate is a medication used to help control bleeding.
What it treats
- heavy menstrual bleeding (menorrhagia)
- bleeding after surgery
- bleeding due to injury
How it works
Etamsylate helps to improve blood clotting, which reduces bleeding.
Who it's for
This medicine is for people who experience excessive bleeding or need support after surgery.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About inj
Inj is a medication used to treat various health conditions.
How it works
Inj works by affecting certain processes in the body to help manage symptoms or treat conditions.
Who it's for
Inj is prescribed for patients with specific medical needs as determined by a healthcare professional.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: etamsylate
BNF-referencedEtamsylate is a synthetic compound primarily used for its haemostatic properties. It is indicated for the treatment of various bleeding disorders, including menorrhagia and other forms of abnormal uterine bleeding. The drug works by enhancing capillary stability and reducing excessive bleeding.
Indications
- Menorrhagia
- Abnormal uterine bleeding
- Prevention of bleeding during surgical procedures
- Post-operative bleeding
Dosage
Children: Refer to the BNF for Children for specific dosing guidelines.
Adults: Refer to the BNF for specific dosing guidelines.
Mechanism of action
Etamsylate enhances the stability of capillaries and reduces their permeability. It promotes platelet aggregation and has a role in the coagulation cascade, though its precise mechanism is not fully understood.
Pharmacodynamics
Etamsylate acts by stabilizing the endothelial cells of capillaries, which helps to prevent leakage of plasma proteins and fluid into tissues, thereby reducing bleeding. The drug has been shown to be effective in various clinical settings, particularly in managing heavy menstrual bleeding.
Pharmacokinetics
Etamsylate is rapidly absorbed after oral administration and reaches peak plasma concentrations within 1 to 3 hours. It is metabolized in the liver, with a significant portion excreted unchanged in urine. The elimination half-life of etamsylate is approximately 3 hours, allowing for flexible dosing schedules.
Adverse effects
- Gastrointestinal disturbances
- Allergic reactions
- Headache
- Dizziness
Precautions
- Use with caution in patients with a history of hypersensitivity to etamsylate or any of its components
- Monitor for signs of bleeding in patients with coagulopathies
Pregnancy
Etamsylate should only be used during pregnancy if the benefits outweigh the risks, as safety in human pregnancy has not been established.
Breast-feeding
Etamsylate is excreted in breast milk, and caution is advised when administering to nursing mothers.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Formulations
- Tablets
- Injectable solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: etamsylate
PubChem CID 17506Molecular formula: C6H6O5S.C4H11N
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.